Aldose reductase inhibitors: therapeutic implications for diabetic complications

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.12, 1999-12, pp. : 2095-2119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 2, 2016-01 ,pp. : 120-162

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Analysis of Aldose Reductase in Diabetic Complications

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1375-1387

Bentham Science Publishers

Access to resources Recommend Favorite

New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications

By Costantino L. Rastelli G. Cignarella G. Vianello P. Barlocco D.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 8, 1997-08 ,pp. : 843-858

Informa Healthcare

Access to resources Recommend Favorite